Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA Vaccines market report explains the definition, types, applications, major countries, and major players of the RNA Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
BioNTech
eTheRNA
Sangamo Therapeutics
Translate Bio
Moderna Therapeutics
Argos Therapeutics
Ethris
Tiba Biotechnology
In-Cell-Art
CureVac
By Type:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User:
Infectious Disease
Cancer
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global RNA Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 RNA Vaccines Outlook to 2028- Original Forecasts
-
2.2 RNA Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term RNA Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global RNA Vaccines Market- Recent Developments
-
6.1 RNA Vaccines Market News and Developments
-
6.2 RNA Vaccines Market Deals Landscape
7 RNA Vaccines Raw Materials and Cost Structure Analysis
-
7.1 RNA Vaccines Key Raw Materials
-
7.2 RNA Vaccines Price Trend of Key Raw Materials
-
7.3 RNA Vaccines Key Suppliers of Raw Materials
-
7.4 RNA Vaccines Market Concentration Rate of Raw Materials
-
7.5 RNA Vaccines Cost Structure Analysis
-
7.5.1 RNA Vaccines Raw Materials Analysis
-
7.5.2 RNA Vaccines Labor Cost Analysis
-
7.5.3 RNA Vaccines Manufacturing Expenses Analysis
8 Global RNA Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global RNA Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global RNA Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global RNA Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global RNA Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise RNA Vaccines Market Analysis and Outlook till 2022
-
10.1 Global RNA Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States RNA Vaccines Consumption (2017-2022)
-
10.2.2 Canada RNA Vaccines Consumption (2017-2022)
-
10.2.3 Mexico RNA Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany RNA Vaccines Consumption (2017-2022)
-
10.3.2 UK RNA Vaccines Consumption (2017-2022)
-
10.3.3 Spain RNA Vaccines Consumption (2017-2022)
-
10.3.4 Belgium RNA Vaccines Consumption (2017-2022)
-
10.3.5 France RNA Vaccines Consumption (2017-2022)
-
10.3.6 Italy RNA Vaccines Consumption (2017-2022)
-
10.3.7 Denmark RNA Vaccines Consumption (2017-2022)
-
10.3.8 Finland RNA Vaccines Consumption (2017-2022)
-
10.3.9 Norway RNA Vaccines Consumption (2017-2022)
-
10.3.10 Sweden RNA Vaccines Consumption (2017-2022)
-
10.3.11 Poland RNA Vaccines Consumption (2017-2022)
-
10.3.12 Russia RNA Vaccines Consumption (2017-2022)
-
10.3.13 Turkey RNA Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China RNA Vaccines Consumption (2017-2022)
-
10.4.2 Japan RNA Vaccines Consumption (2017-2022)
-
10.4.3 India RNA Vaccines Consumption (2017-2022)
-
10.4.4 South Korea RNA Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan RNA Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh RNA Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia RNA Vaccines Consumption (2017-2022)
-
10.4.8 Thailand RNA Vaccines Consumption (2017-2022)
-
10.4.9 Singapore RNA Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia RNA Vaccines Consumption (2017-2022)
-
10.4.11 Philippines RNA Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam RNA Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil RNA Vaccines Consumption (2017-2022)
-
10.5.2 Colombia RNA Vaccines Consumption (2017-2022)
-
10.5.3 Chile RNA Vaccines Consumption (2017-2022)
-
10.5.4 Argentina RNA Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela RNA Vaccines Consumption (2017-2022)
-
10.5.6 Peru RNA Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico RNA Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador RNA Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain RNA Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait RNA Vaccines Consumption (2017-2022)
-
10.6.3 Oman RNA Vaccines Consumption (2017-2022)
-
10.6.4 Qatar RNA Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia RNA Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates RNA Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria RNA Vaccines Consumption (2017-2022)
-
10.7.2 South Africa RNA Vaccines Consumption (2017-2022)
-
10.7.3 Egypt RNA Vaccines Consumption (2017-2022)
-
10.7.4 Algeria RNA Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia RNA Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand RNA Vaccines Consumption (2017-2022)
11 Global RNA Vaccines Competitive Analysis
-
11.1 BioNTech
-
11.1.1 BioNTech Company Details
-
11.1.2 BioNTech RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 BioNTech RNA Vaccines Main Business and Markets Served
-
11.1.4 BioNTech RNA Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 eTheRNA
-
11.2.1 eTheRNA Company Details
-
11.2.2 eTheRNA RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 eTheRNA RNA Vaccines Main Business and Markets Served
-
11.2.4 eTheRNA RNA Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sangamo Therapeutics
-
11.3.1 Sangamo Therapeutics Company Details
-
11.3.2 Sangamo Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sangamo Therapeutics RNA Vaccines Main Business and Markets Served
-
11.3.4 Sangamo Therapeutics RNA Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Translate Bio
-
11.4.1 Translate Bio Company Details
-
11.4.2 Translate Bio RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Translate Bio RNA Vaccines Main Business and Markets Served
-
11.4.4 Translate Bio RNA Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Moderna Therapeutics
-
11.5.1 Moderna Therapeutics Company Details
-
11.5.2 Moderna Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Moderna Therapeutics RNA Vaccines Main Business and Markets Served
-
11.5.4 Moderna Therapeutics RNA Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Argos Therapeutics
-
11.6.1 Argos Therapeutics Company Details
-
11.6.2 Argos Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Argos Therapeutics RNA Vaccines Main Business and Markets Served
-
11.6.4 Argos Therapeutics RNA Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Ethris
-
11.7.1 Ethris Company Details
-
11.7.2 Ethris RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Ethris RNA Vaccines Main Business and Markets Served
-
11.7.4 Ethris RNA Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Tiba Biotechnology
-
11.8.1 Tiba Biotechnology Company Details
-
11.8.2 Tiba Biotechnology RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Tiba Biotechnology RNA Vaccines Main Business and Markets Served
-
11.8.4 Tiba Biotechnology RNA Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 In-Cell-Art
-
11.9.1 In-Cell-Art Company Details
-
11.9.2 In-Cell-Art RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 In-Cell-Art RNA Vaccines Main Business and Markets Served
-
11.9.4 In-Cell-Art RNA Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 CureVac
-
11.10.1 CureVac Company Details
-
11.10.2 CureVac RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 CureVac RNA Vaccines Main Business and Markets Served
-
11.10.4 CureVac RNA Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global RNA Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global RNA Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global RNA Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise RNA Vaccines Market Analysis and Outlook to 2028
-
13.1 Global RNA Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States RNA Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada RNA Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico RNA Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia RNA Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey RNA Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines RNA Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam RNA Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico RNA Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador RNA Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain RNA Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait RNA Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman RNA Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar RNA Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia RNA Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates RNA Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria RNA Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa RNA Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt RNA Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria RNA Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia RNA Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand RNA Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of RNA Vaccines
-
Figure of RNA Vaccines Picture
-
Table Global RNA Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global RNA Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Vaccines Consumption by Country (2017-2022)
-
Table North America RNA Vaccines Consumption by Country (2017-2022)
-
Figure United States RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe RNA Vaccines Consumption by Country (2017-2022)
-
Figure Germany RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC RNA Vaccines Consumption by Country (2017-2022)
-
Figure China RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America RNA Vaccines Consumption by Country (2017-2022)
-
Figure Brazil RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC RNA Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa RNA Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania RNA Vaccines Consumption by Country (2017-2022)
-
Figure Australia RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table BioNTech Company Details
-
Table BioNTech RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech RNA Vaccines Main Business and Markets Served
-
Table BioNTech RNA Vaccines Product Portfolio
-
Table eTheRNA Company Details
-
Table eTheRNA RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA RNA Vaccines Main Business and Markets Served
-
Table eTheRNA RNA Vaccines Product Portfolio
-
Table Sangamo Therapeutics Company Details
-
Table Sangamo Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics RNA Vaccines Main Business and Markets Served
-
Table Sangamo Therapeutics RNA Vaccines Product Portfolio
-
Table Translate Bio Company Details
-
Table Translate Bio RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Translate Bio RNA Vaccines Main Business and Markets Served
-
Table Translate Bio RNA Vaccines Product Portfolio
-
Table Moderna Therapeutics Company Details
-
Table Moderna Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics RNA Vaccines Main Business and Markets Served
-
Table Moderna Therapeutics RNA Vaccines Product Portfolio
-
Table Argos Therapeutics Company Details
-
Table Argos Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics RNA Vaccines Main Business and Markets Served
-
Table Argos Therapeutics RNA Vaccines Product Portfolio
-
Table Ethris Company Details
-
Table Ethris RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ethris RNA Vaccines Main Business and Markets Served
-
Table Ethris RNA Vaccines Product Portfolio
-
Table Tiba Biotechnology Company Details
-
Table Tiba Biotechnology RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiba Biotechnology RNA Vaccines Main Business and Markets Served
-
Table Tiba Biotechnology RNA Vaccines Product Portfolio
-
Table In-Cell-Art Company Details
-
Table In-Cell-Art RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table In-Cell-Art RNA Vaccines Main Business and Markets Served
-
Table In-Cell-Art RNA Vaccines Product Portfolio
-
Table CureVac Company Details
-
Table CureVac RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac RNA Vaccines Main Business and Markets Served
-
Table CureVac RNA Vaccines Product Portfolio
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
